john eisenbrey: Clinical Trials

2 trials sponsored by john eisenbrey, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2

Follow john eisenbrey: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
Sulfur Hexafluoride Lipid Microspheres, Contrast-Enhanced Ultrasound, Transarterial Chemoembolization - Liver Neoplasms
Phase 2Recruitingjohn eisenbrey2662024-08-072026-02-17
Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation
Sulfur Hexafluoride Lipid Microspheres, Contrast-Enhanced Ultrasound, Computed Tomography - Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma
Phase 2Recruitingjohn eisenbrey2102022-11-032026-02-17

Conditions studied

Carcinoma, Renal Cell (1)  ·  Liver Neoplasms (1)

Interventions

Chemoembolization, Therapeutic (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  X-Rays (1)

Countries

United States (2)

NIH funding

R01CA194307 (1), R01CA269750 (1)